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Abstract
Although N-myc amplification and overexpression are
believed to play an important role in determining the
clinical behavior of neuroblastoma (NB), the exact
function of N-myc in NB cell growth and differentiation
remains unknown. To better understand the function of
N-myc, an established human NB cell line was
transfected with N-myc antisense (AS) complementary
DNA in an effort to down-regulate N-myc gene
expression. Five clones expressing AS N-myc RNA have
been maintained in culture for over 2 years. Compared
to control cells, a 30-69% decrease in the quantity of
N-myc protein was demonstrated by Western blot
analysis in 4 of the 5 AS clones. All 5 of the AS clones
exhibited a 50-75% decrease in colony formation in soft
agar assays compared to control cells. In addition, all 5
AS clones expressed a 3.2-kilobase protein kinase C-a
transcript, whereas this message was not detected by
Northern blot analysis in any of the control clones.
These results suggest that N-myc may play an important
role in NB cell growth and that antisense N-myc
expression is associated with an induction of protein
kinase C-a RNA expression. Further characterization of
the AS clones may provide insight into the function of
N-myc and may thus lead to a better understanding
of the role that N-myc plays in determining the clinical
behavior of this childhood neoplasm.
Introduction
N-myc oncogene amplification and high levels of expres-
sion in human NB3 have been correlated with advanced
stages of disease and rapid tumor progression (1 , 2), sug-
gesting that N-myc plays an important role in determining
the biological behavior of NB. Furthermore, enhanced
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N-myc expression through exogenous gene transfer has
been associated with an increased in vivoand in vitro growth
rate and metastatic potential in both a rat and a human NB
model (3, 4). Recently, high levels of N-mycexpression have
been shown to perturb PKC-mediated signal transduction in
a rat NB model (5), indicating that N-myc may affect PKC
activation.
N-myc may also be crucial for neural crest cell differen-
tiation, as N-myc mRNA and protein are expressed in a tran-
sient and organ-specific fashion during fetal and postnatal
development, whereas N-myc is not detected in mature tis-
sues (6). N-myc isexpressed inthe fetalbrain up to the onset
of differentiation, and it is also present at high levels in neu-
roblasts migrating from the neural crest through the adrenal
cortex (7). However, only low levels of N-myc are detected
in neuroblasts forming the adrenal medulla. Down-
regulation of N-myc is also seen in NB cells chemically in-
duced to differentiate, and constitutive expression of N-myc
via exogenous gene transfer can block retinoic acid-induced
differentiation (8, 9). These observations indicate that N-myc
may be involved in the regulation of neural crest cell dif-
ferentiation. Recently, two groups have produced mice ho-
mozygous for a targeted disruption of the N-myc gene (10,
11). The homozygous mutant embryos die between 10.5
and 12.5 days of gestation, and histological analysis of the
mutant embryos reveals multiple defects in several devel-
oping organs, including the central and peripheral nervous
systems, mesonephros, lung, gut, and heart, indicating that
N-myc function is required during embryogenesis.
N-myc is a member of the MYC family of genes, which
share structural similarities in helix-loop-helix DNA-binding
domains with other trans-acting differentiation factors such
as MyoD and E2A (1 2, 13). This motif is thought to be re-
sponsible for both DNA binding and dimerization. Recently,
the MYC proteins have been shown to form a sequence-
specific DNA-binding complex with MAX, another helix-
loop-helix leucine zipper protein (13, 14), suggesting that
the MYC proteins are DNA-binding transcription factors. It
is, therefore, likely that N-myc is a trans-acting factor in-
volved in regulating the expression of key cellular genes.
However, the exact function of N-myc remains unknown.
In an effort to determine the function of N-myc and its role
in NB cell growth and differentiation, we transfected the
human NB cell line NBL-S with an expression vector con-
taming AS N-myc cDNA. NBL-S cells lack N-myc amplifi-
cation, but the in vitro and in vivo cell growth kinetics par-
allel those reported in N-myc-amplified NB cell lines (1 5).
In addition, owing to a prolonged half-life of the protein,
N-myc protein levels in NBL-S are similar to the quantity
detected in N-myc-amplified NB cell lines. However, com-
pared to the amplified cell line IMR-5, -20-fold less N-myc
RNA is expressed in NBL-S. Thus, a relatively small pool of
endogenous N-myc mRNA is present in these cells, making
the NBL-S cell line ideal for N-myc AS experiments.,r￿ ‘￿) I
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Fig. 1. Southern blot analysis. Twenty pg of genomic DNA from each cell line and the transfected NBL-S clones were restricted with EcoRl, electrophoresed
on agarose gels, transferred to filters, and hybridized with the 32P-labeled pNB-l N-myc probe. Arrows, the endogenous N-myc signal (2.0 kb( and the AS N-myc
cDNA insert (1.2 kb(.
Results
A 1 .2-kb N-myc cDNA fragment was cloned into the EcoRI
site ofthe pCMV2 expression vector in the sense or antisense
orientation. This expression vector contains human cyto-
megalovirus immediate early gene promoter sequences
which drive expression of cloned DNA. The human growth
hormone gene sequences provide the transcription termi-
nation and polyadenylation signals (16, 17). Five stable
clones (NBAS-1 ,NBAS-2, NBAS-3, NBAS-4, and NBAS-5),
which constitutively express AS N-myc RNA, have been es-
tablished from human NBL-S NB cells transfected with the
pCMV2 vector containing AS N-myccDNA. In addition, four
control clones have been established from NBL-S cells trans-
fected with either pCMV2 containing sense N-myc cDNA
(NBS-1 and NBS-2) or the pCMV2 vector lacking N-myc
cDNA (NBV-1 and NBV-2).
The transfected cells appear morphologically similar to
the untransfected parent cells, show moderate substrate ad-
herence, and form short neurite-like processes. Southern
blot analysis demonstrates the presence of a single copy of
the AS N-myc cDNA integrated into each antisense clone
(Fig. 1 ). However, exogenous N-myc DNA was not detected
in any of the clones transfected with constructs containing
the 1 .2-kb N-myc cDNA in the sense orientation. To deter-
mine whether vector sequences were present in all trans-
fected NBL-S cells, the Southern blot was rehybridized to a
720-bp probe for the CMV promoter. Integrated vector se-
quences were detected in all of the vector, sense, and AS
transfected clones (data not shown). It remains unclear why
integration of exogenous sense N-myc cDNA did not occur,
but it is possible that the truncated 1 .2-kb sense N-myc
cDNA is unstable or toxic to the cells.
An N-rnyc cDNA probe (15) specifically hybridized to
endogenous N-mycmRNA(3.2 kb) in all ofthe NB cell lines
by Northern blot analysis (Fig. 2). The probe also hybridized
to a 1 .7-kb transcript in the AS transfected clones, the ex-
pected size ofthe N-mycAS transcript, which consists of the
1.2-kb N-myc cDNA fragment, 100 bp of human growth
hormone untranslated sequences including the polyade-
nylation and transcription termination signals, and a
poly(A)￿ tail of about 400 bp. In each lane containing AS
RNA, 0.9-kb and 0.66-kb transcripts were also detected.
These smaller transcripts may be due to multiple start sites
within the AS cDNA. By densitometric analysis, the ratio of
AS N-myc RNA (1 .7-kb transcript) to endogenous N-myc
mRNA expression was found to vary from 2 to 5. As ex-
pected, transcripts other than the 3.2-kb endogenous N-myc
message were not detected in the control clones NBV-1,
NBS-1, or NBS-2.
To confirm that the smaller transcripts observed in the AS
clones represented N-myc AS sequences, a Northern blot
analysis was performed using an in vitro transcribed N-myc
sense RNA probe. The sense riboprobe hybridized only to
the 1 .7-, 0.9-, 0.66-kb transcripts expressed in the AS clones.
The 3 .2-kb endogenous N-myc message was not detected by
this sense RNA probe (data not shown). To determine
whether the transfected cells expressed message for the neo-
mycin resistance gene, a dot blot containing poIy(A)￿ RNA
isolated from the NBL-S parent cell line, the promyelocytic
leukemia HL-60 cell line, and the transfected clones was
hybridized with a 2.4-kb cDNA probe for the neomycin re-
sistance gene isolated from pSV2neo. The probe hybridized
to mRNA isolated from all of the NBL-S transfected clones
but not to mRNA isolated from the untransfected parent cell
line NBL-S or HL-60 cells (data not shown).
N-myc protein expression was analyzed by Western blot
analysis using the anti-N-myc monoclonal antibody NCM II
100 (18). The antibody reacted strongly with cellular pro-
teins having the expected molecular weight of approxi-
mately 62,000-64,000 in all NB cells analyzed (Fig. 3).
Densitometric analysis ofthe Western blot revealed approxi-
mately a 30-69% decrease in N-myc protein expression in
4 of 5 AS clones compared to untransfected NBL-S cells or
NBV-1 . Levels of N-myc protein similar to those of controls
were seen in one AS clone (NBAS-1 ). Somewhat higher 1ev-
els of N-myc protein were observed in NBS-1 and NBS-2
than in NBL-S and NBV-1 . Protein extracted from the nega-
tive control, the HL-60 cell line, did not react with the
N-myc antibody. Three Western blot experiments were per-
formed, and consistent results were obtained. To document
equal loading and transfer of total protein, the filters were
stained with amido black or Ponceau S, and these studies
indicated thatsimilarquantitiesoftotal protein were present
in each lane (data not shown).
To determine whether down-regulation of N-myc expres-
sion resulted in changes in tumor cell growth, soft agar4.40 Kb-*
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Fig. 2. Northern blot analysis. Forty pg of
total RNA from each cell line and the trans-
fected NBL-S clones were electrophoresed
on formaldehyde-agarose gels, transferred
to filters, and hybridized with an N-myc
cDNA probe. Top panel, the endogenous
N-myc message (3.2 kb( and the N-myc AS
transcripts (1 .7, 0.9, and 0.66 kb) (arrows).
Bottom panel, the blot was stripped and re-
hybridized with a j3-actin probe.
1.35 Kb-#{247}
4- 3.2 Kb
4- 1.7 Kb
4- 0.9 Kb
4- 0.66 Kb
U)
.<
,.-, 4-N:rnyc
Protein
Fig. 3. Western blot analysis. Total protein (10 pg( from each cell line was
electrophoresed in a sodium dodecyl sulfate-polyacrylamide gel, transferred
to nitrocellulose paper, and incubated with the N-myc NCM II 100 mono-
clonal antibody. Arrow, N-niyc signals (62-64 kilodaltons( detected with the
antibody.
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colony formation assays were performed. Four weeks after
plating the cells, there were 50-75% less colonies/dish in all
five AS clones compared to the NBL-S parent cell line and
the clones transfected with control vectors (Fig. 48). In ad-
dition, the colonies detected in the dishes containing AS
clones were smaller. Representative experiments are shown
in Fig. 4A. One-way analysis of variance comparing the
number ofcolonies in the AS experiments to the controls was
statistically significant (P< 0.0001).
Expression of PKC-a mRNA was analyzed to ascertain
whether alterations in N-myc expression resulted in changes
in the expression of PKC-a. A 3.2-kb PKC-a transcript was
detected by Northern blot analysis in all five AS clones (Fig.
5). This transcript was not detected in NBL-S, IMR-5, SH-
SY5Y, HL-60, NBV-2, NBS-1 , or NBS-2.
Discussion
Prior studies have demonstrated that introduction of anti-
sense cDNA which is complementary to a specific mRNA is
a useful method for investigating gene products of unknown
function (19, 20). AS RNA presumably forms stable RNA-
RNA hybrids which result in a block oftranslation and, thus,
effectively creates a null-mutant phenotype (21). Signifi-
cantly decreasing the quantity of a gene product by use of
the antisense strategy provides insight into the molecular
activities of the normal counterpart and enables one to de-
terminethe contribution ofthe encoded protein to the physi-
ology and development of the cell.
In an effort to determine the function of the N-myc on-
cogene, five stable human NB clones which constitutively
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express AS N-myc have been established and passaged in
tissue culture for more than 2 years. Although Southern blot
analysis demonstrated the presence of a single copy of the
N-myc AS cDNA integrated into each AS clone (Fig. 1 ), the
quantity of AS transcript expressed was found to vary from
2- to 5-fold greater than endogenous N-myc mRNA (Fig. 2).
Northern blot analysis repeated after different passages in
culture demonstrated that the level of AS N-myc expression
in each clone has remained constant over time (data not
shown).
The level of N-myc protein detected in each AS clone
ranged from similar to that present in untransfected NBL-S
(NBAS-1 ) to a 30-69% decrease (NBAS-2, NBAS-3, NBAS-4,
and NBAS-5) (Fig. 3). It is likely that complete inhibition of
N-myc protein expression results in a nonviable phenotype,
because all AS clones continue to express N-myc protein to
some degree. Although integration of exogenous N-mycA
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Fig. 4. Soft agar cLony assays.
A, representative ex￿ t’riments de-
picting colony form￿ition 4 weeks
after plating 2 X li)’ cells. Top
panel, control clones )NBL-S,
NBV-l ,and NBS-l (; bottom panel
AS N-myc clones (NBAS-l,
NBAS-2, and NBAS-5(. B, graphi-
cal depiction of number of cob-
nies observed for the control
clones (NBL-S, NBV-1 , NBV-2,
and NBS-l ) and for the AS clones
(NBAS-l , NBAS-2, NBAS-3,
NBAS-4, and NBAS-5(. Bars, SD.
Cell Line Identification
cDNA was not demonstrated by Southern blot analysis in the
clones transfected with the sense N-myc cDNA, slightly
higher levels of N-myc protein were detected in NBS-1 and
NBS-2, which most likely reflects some heterogeneity of
N-myc protein expression in these cells.
Inhibited NB cell growth in vitro is associated with anti-
sense N-myc expression, as all five AS clones exhibit 50-
75% less colonies in soft agar assays after 4 weeks of growth
compared to control experiments (Fig. 4, A and B). How-
ever, the mechanisms involved in inducing the biological
effects seen in the AS clones remain unclear. The inhibited
cell growth may be due to down-regulated N-myc protein
expression, although decreased N-myc protein was not seen
in 1 of the 5 AS clones (NBAS-1 ). It is possible that NBAS-1
cells express less N-myc protein than control cells, but the
difference may be below the level of detection by Western
blot analysis. Alternatively, the changes in growth may be a
consequence of the expression of the antisense N-myc RNA
independent of its effect on N-myc protein expression. Ex-
pression of AS N-myc RNA may lead to increased levels of
double-stranded RNA, which in turn may activate double-
stranded RNA-dependent kinases. Phosphorylation of the
translation initiation factor eI2F could subsequently result in
altered gene expression and cell growth. However, the de-- e’￿i c￿) ￿
r￿ ￿ r;1 ￿ ￿ C￿) ￿
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Fig. 5. PKC-o mRNA expression.
Total RNA (40 Jg( from each cell
line was analyzed by Northern blot
for PKC-a mRNA expression. Top
panel, a 3.2-kb transcript, detected
only in the 5 N-myc AS clones ar-
row). Bottom panel, the blot was
stripped and rehybridized with a
probe for f3-actin.
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crease in colony formation seen in the AS clones is not likely
to be secondary to the presence of heterologous RNA ex-
pression, as neomycin resistance gene mRNA is present in
the control transfected clones which exhibit similar patterns
of tumor cell growth in soft agar assays as the NBL-S parent
cell line.
Yokoyama and Imamoto (22) successfully down-
regulated c-myc in HL-60 cells by transfecting the cells with
an expression vector containing AS c-myc, and prolongation
ofthe cell cycle was demonstrated. In addition, the AS cells
differentiated to a monocytic phenotype, suggesting that
c-myc is an important factor in cell cycle timing and may
also play a role in regulating differentiation in HL-60 cells.
Recently, Collins etal. (23) reported a 40-75#{176}kdecrease in
colony formation in soft agar assays in Cob 320 colonic
carcinoma cells treated with AS c-myc oligonucleotides.
Thus, similar to our results, a direct correlation between the
down-regulation of a MYC family protein and inhibition of
tumor cell growth was demonstrated.
Rosolen and coworkers (24) down-regulated N-myc in a
neuroepithelioma cell line by treating the cells with N-myc
AS oligonucleotides, and a decrease in proliferation was oh-
served after 6 days. Similarly, Negroni et al. (25) demon-
strated an inhibition in the rate of replication in NB cells
(LA-N-5) treated with N-myc AS oligonucleotides for 90 h.
Whitesell and colleagues (26) suppressed N-myc expression
in CHP-100 neuroepithelioma cells and the N-myc ampli-
fied NB cell line IMR-32 with episome-generated N-mycAS
RNA. An inhibition in phenotypic transdifferentiation was
observed in the transfected IMR-32 cells, and a slower in
vitro growth rate was detected in the CHP-1 00 cells express-
ing N-mycAS RNA. However, loss of in vivotumorigenicity
was not observed with the AS CHP-1 00 cells. Future studies
will be completed to determine whether the NBL-S AS
clones, reported in this study, exhibit decreased tumor
growth in nude mice compared to controls.
Recently, high levels of N-myc expression have been re-
ported to result in disruption of PKC-mediated signal trans-
duction in rat NB cells transfected with exogenous N-myc
(5). The transfected cells had an altered pattern of PKC ex-
pression compared to that present in the untransfected NB
cells, and phorbol ester failed to activate the NF-KB tran-
scription factor or induce c-fos in the N-myc-transfected
cells. To determine whether down-regulation of N-myc also
resulted in an altered pattern of PKC expression, we exam-
med PKC-a expression in the AS and control clones. A
3.2-kb PKC-ct transcript was detected by Northern blot
analysis in RNA isolated from all five AS clones which was
not detected in either the parent cell line or any of the con-
trols (Fig. 5). Thus, a correlation between antisense N-rnyc
expression and enhanced PKC-a expression was seen.
The PKCfamily is comprised ofsix genes, from which nine
proteins (a, f3 I and II, y, #{128}, B, ￿, N, and L) are translated
(27-29). PKC isozymes are involved in a wide variety of
cellular responses. In some cells, PKC proteins act as mito-
gens to stimulate growth, whereas in other systems, PKC
induces cell differentiation and inhibits proliferation (28-
35). For example, down-regulation of PKC-a was seen in the
human NB cell line SK-N-Be(2)c induced to differentiate
with retinoic acid (35). Conversely, two groups have recently
reported induction of PKC-a message and morphological
differentiation in the NB cell line SH-SY5Y, treated with low
doses of 12-O-tetradecanoylphorbol-1 3-acetate (33, 34). Al-
though low levels of PKC-a mRNA were detected by North-176 Antisense N-myc Expression in Human Neuroblastoma
em blot analysis in untreated SH-SY5Y cells in one of these
studies (33), we were not able to detect PKC-a transcripts in
untreated SH-SY5Y cells. The contrasting pattern of PKC-a
expression may be due to changes that have occurred in this
cell line during passage in culture. Because PKC phosphory-
lates a number of cell surface receptors which are involved
in mediating controlled cell growth and differentiation, it is
tempting to speculate that the up-regulated PKC-a expres-
sion detected in the AS clones may be playing a role in
inhibiting NB cell growth in the soft agar assays. Studies are
ongoing to determine whether PKC-mediated signal trans-
duction has been restored in the AS cells.
Our studies demonstrate that antisense N-myc expression
is associated with inhibited NB cell growth in vitro and an
induction of PKC-a expression. Further characterization of
the AS clones with down-regulated N-myc expression may
lead to the identification of other genes which are regulated
directly or indirectly by N-myc. Such studies may provide
insight into both the function of N-myc as well as the role
N-myc plays in determining the biological behavior of hu-
man NB.
Materials and Methods
CellCulture. All cell lines were cultured in RPMI 1640 me-
dia (GIBCO-BRL, Grand Island, NY) supplemented with
10% heat-inactivated fetal bovine serum (GIBCO-BRL), glu-
tamine (Irvine Scientific, Santa Ana, CA), and antibiotics.
NBL-S (1 5) is an N-myc unamplified human NB cell line
[established in one of our laboratories (S. L. C.)]. IMR-5, a
clone of the human NB cell line IMR-32 (36), has 25 copies
of the N-myc gene (a gift from Dr. Alan Epstein, University
ofSouthern California, Los Angeles, CA). LA-N-5 is a human
NB cell line with 100 copies of the N-myc gene (37) (a gift
from Dr. Robert Seeger, LA Children’s Hospital, Los Angeles,
CA). SK-N-SH is a human neuroblastoma cell line which
lacks N-mycamplification (ATCC, Rockville, MD) (38). SH-
SY5Y is a subclone of SK-N-SH (a gift from Dr. June Biedler,
Memorial Sloan-Kettering, New York, NY) (39). HL-60 is a
c-myc-amplified human promyelocytic leukemia cell line
(ATCC).
Plasmid Constructs. A 1 .2-kb N-myc cDNA, previously
isolated from a human NB cDNA library (1 5), was partially
sequenced using the dideoxy method of Sanger et al. (40)
and found to extend from nucleotide 465 within exon 1 to
nucleotide 5190 within exon 3; it thus includes the trans-
lation initiation site within exon 2 (41 ). This N-myc cDNA
fragment was cloned into the EcoRI site ofthe pCMV2 vector
(42) (a generous gift from Dr. Mark F. Stinski, University of
Iowa, Iowa City, IA), in the sense or AS orientation. The
promoter sequences in the pCMV2 vector are derived from
the human cytomegalovirus (Towne strain) major immediate
early gene (nucleotides -760 to +3) (1 6). Expression of AS
sequences is driven by this promoter, and transcription ter-
mination and polyadenylation signals are provided by the
human growth hormone fragment (nucleotides 1 533-21 57)
(1 7). Restriction enzyme analysis was used to confirm the
appropriate orientation ofthe N-myccDNA within the plas-
mids.
Transfection Experiments. Cotransfections were per-
formed with the pSV2neo plasmid (ATCC) and either the
control pCMV2 plasmid or pCMV2 containing sense or AS
N-myc cDNA by electroporation or calcium phosphate-
mediated DNA precipitation. Electroporation was carried
out at 22#{176}C using 1 .6 X 106 cells resuspended in 0.8 ml of
Dulbecco’s modified Eagle’s medium (GIBCO-BRL) with 10
pg of test plasmid and 1 pg of pSV2neo plasmid. The Cell-
Porator (GIBCO-BRL) was used with a field strength of 775
V/cm and a pulse length of 13.2 ms. Calcium phosphate
precipitation was performed as previously described (43),
using 5 pg of test plasmid and 0.5 pg of pSV2neo plasmid.
Cells (2 X 106) were incubated with the DNA precipitate for
3.5 h, shocked with 15% glycerol, and then refed with com-
plete media. Forty-eight h after electroporation or calcium
phosphate precipitation, 400 pg/mI of G41 8 (GIBCO-BRL)
were added to the media. Neomycin-resistant clones were
isolated and expanded and have been maintained in con-
tinuous culture for over 2 years.
Southern Blot Analysis. High-molecular-weight DNA
was isolated from cells by standard techniques (44). South-
em blotting was performed using 20 pg of DNA from IMR-5,
LA-N-5, SK-N-SH, NBL-S, and the transfected NBL-S clones.
The DNA was digested with EcoRI (GIBCO-BRL) as de-
scribed elsewhere (45), and the blot was hybridized with the
32P-labeled pNB-1 N-myc probe (1 2). The blot was stripped
and rehybridized with a 720-hp probe for the CMV promoter
which extends from the Sau3Al restriction site to the A/uI site
(16).
Northern Blot Analysis. Total cellular RNA was extracted
from theAS clones and control cell lines usingthe single-step
method of RNA isolation with acid guanidmnium
thiocyanate-phenol-chloroform extraction (46). Northern
blotting was performed with 40 pg of total RNA using stand-
ard methods (47). The filters were hybridized with the 32P-
labeled human N-myc cDNA probe (1 5) or the human
PKC-a probe (ATCC). The PKC-a cDNA probe is 1.29 kb in
size and extends from downstream ofthe initiation codon to
before the termination codon (48). The 1 .2-kb N-myccDNA
fragment was cloned into the SP64 vector (Promega, Madi-
son, WI) and an in vitrotranscribed 32P-Iabeled 1 .2-kb sense
N-myc RNA probe was prepared using SP6 RNA polymerase
according to the manufacturer’s instructions. Northern blots
were hybridized with the in vitro transcribed N-myc sense
RNA probe as described above. After each blot was auto-
radiographed, it was stripped and hybridized with the
pHFBA-1 ￿3-actin probe (49). The signals were quantified by
laser densitometry, and after standardization to actin, the
ratio of expression of AS to endogenous N-myc was deter-
mined.
Dot Blot Analysis. Poly(A)￿ RNA was isolated by a single
fractionation on oligo(dT) cellulose (Collaborative Biomedi-
cal Products, Bedford, MA) (50) from all of the transfected
clones, the NBL-S cell line, and the HL-60 cell line. One, 0.5,
0.25, and 0.1 25 pg of RNA from each sample was loaded
onto a filter using a dot blotter(Bio-Rad, Richmond, CA) (51).
For a positive control, 50 ng of neomycin resistance gene
DNA isolated from pSV2neo were blotted onto the filter. The
filter was hybridized to a 32P-Iabeled 2.4-kb probe for the
neomycin resistance gene as previously described (51). The
probe was isolated from pSV2neo using the restriction en-
zymes BamHl and Hindlll.
Western Blot Analysis. Cell extracts were prepared by
methods previously described (1 8), and protein was quan-
tified in each sample using the Bio-Rad protein assay reagent
(Bio-Rad) according to the manufacturer’s instructions. Ten
pg of total cellular protein/sample were electrophoresed in
a sodium dodecyl sulfate-polyacrylamide gel and transferred
to nitrocellulose paper using standard techniques (52). Fol-
lowing incubation with the N-myc monoclonal antibody
NCM II 100 (1 8) and treatment with 0.25% glutaraldehydeCell Growth & Differentiation 177
to stabilize the binding of the antibody, the filter was ex-
posed to a goat anti-mouse biotinylated secondary antibody
(Kirkegaard and Perry Laboratories, Gaithersburg, MD) and
developed using the ECL chemiluminescence procedure
(Amersham, Arlington Heights, IL). Each blot was then ex-
posed to Hyperfilm (Amersham) for 10 s to 3 mm. The bands
were quantified by laser densitometry. Three separate West-
em blot experiments were performed with protein extracts
isolated at three different times. To document that equal
amounts ofprotein were loaded and transferred in each lane,
the filters were stained with either Ponceau S (Sigma, St.
Louis, MO) (53) or amido black (Bio-Rad) (54).
Soft AgarClonogenic Assay. Approximately 2 x 10￿ cells
from the five AS clones, the parent NBL-S cells, and the
transfected control clones were plated on an upper layer of
0.3% Bacto-Agar (Difco Laboratories, Detroit, Ml) in RPMI
1640 (GIBCO-BRL) and 20% fetal bovine serum over an
underlayer of 0.51 % Bacto-Agar with 20% fetal bovine se-
rum, RPMI 1640, and antibiotics in a 35-mm dish. Three
separate experiments were performed in triplicate, and cob-
nies were counted on day 28 with a Plaque Viewer (BelIco,
Vineland, NJ). One-way analysis of variance to compare the
number of colonies present in each experiment was per-
formed using BMDP statistical software (BMDP Statistical
Software, Los Angeles, CA), and Duncan’s multiple range
test was performed at 0.05 (55).
Addendum
Since submission ofthis paper, a sixth antisense N-myc neuroblastoma clone
has been characterized (NBAS-6). These cells express approximately 50% less
N-myc protein than the parent cell line, NBL-S, and exhibit a 75% decrease
in soft agar colony formation after 28 days of incubation. In addition, these
cells express antisense N-myc transcripts and protein kinase C-a mRNA.
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